Drug ID: | NPD3455 |
Drug Name: | XP-21279 |
Molecular Formula: | C19H21NO6 |
Canonical SMILES: | C[C@@H](OC(=O)c1ccccc1)COC(=O)[C@H](Cc1ccc(c(c1)O)O)N |
Standard InCHI: | InChI=1S/C19H21NO6/c1-12(26-18(23)14-5-3-2-4-6-14)11-25-19(24)15(20)9-13-7-8-16(21)17(22)10-13/h2-8,10,12,15,21-22H,9,11,20H2,1H3/t12-,15+/m1/s1 |
Standard InCHIKey: | AKUWZLYXAADOTQ-DOMZBBRYSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB014362 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 359.14 |
ALogP | -1.9349 |
MLogP | 2.78 |
XLogP | 3.613 |
HDA | 5 |
HBD | 3 |
Rotatable Bonds | 13 |
TPSA | 119.08 |
RO5 Violation | 0 |